Maravai LifeSciences Holdings (MEX:MRVI) Market Cap: MXN16,513 Mil (As of Jun. 30, 2026)


MEX:MRVI Maravai LifeSciences Holdings Inc MEX:MRVI
62 GF Score
Price MXN85.00
GF Value MXN52.37
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Market Cap?

Maravai LifeSciences Holdings MEX:MRVI 62 Market Cap is MXN16,513 Mil as of Jun. 30, 2026. GuruFocus rates MEX:MRVI with a GF Score™ of 62/100 and a GF Value™ of MXN52.37. The stock has 8 warning signs investors should review. Among 1,428 Biotechnology companies, Maravai LifeSciences Holdings ranks better than 79.62% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Maravai LifeSciences Holdings's share price for the quarter that ended in Mar. 2026 was MXN85. Maravai LifeSciences Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 147 Mil. Therefore, Maravai LifeSciences Holdings's market cap for the quarter that ended in Mar. 2026 was MXN12,537 Mil.

Maravai LifeSciences Holdings's quarterly market cap increased from Sep. 2025 (MXN12,301 Mil) to Dec. 2025 (MXN12,353 Mil) and increased from Dec. 2025 (MXN12,353 Mil) to Mar. 2026 (MXN12,537 Mil).

Maravai LifeSciences Holdings's annual market cap increased from Dec. 2023 (MXN11,239 Mil) to Dec. 2024 (MXN12,068 Mil) and increased from Dec. 2024 (MXN12,068 Mil) to Dec. 2025 (MXN12,353 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Maravai LifeSciences Holdings's Enterprise Value for Today is MXN21,071 Mil.


Maravai LifeSciences Holdings  (MEX:MRVI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Maravai LifeSciences Holdings Market Cap Related Terms


Maravai LifeSciences Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for Maravai LifeSciences Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maravai LifeSciences Holdings Market Cap Chart

Maravai LifeSciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial 0.00 44,116.82 11,239.38 12,067.96 12,352.54

Maravai LifeSciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,236.43 12,292.28 12,301.03 12,352.54 12,537.16

MEX:MRVI vs LBRX, SLDB, JANX: Market Cap Comparison

For the Biotechnology subindustry, Maravai LifeSciences Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maravai LifeSciences Holdings Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Maravai LifeSciences Holdings's Market Cap falls into.


MEX:MRVI
62GF Score
Maravai LifeSciences Holdings Inc MEX:MRVI
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maravai LifeSciences Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Maravai LifeSciences Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=MXN85*145.324
=MXN12,353

Maravai LifeSciences Holdings's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=MXN85*147.496
=MXN12,537

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of MXN16,513 Mil mean?
Maravai LifeSciences Holdings (MEX:MRVI) has a Market Cap of MXN16,513 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Maravai LifeSciences Holdings and its competitors. According to the industry distribution chart, Maravai LifeSciences Holdings ranks #291 out of 1428 companies in the Biotechnology industry, placing it in the top 20.4%.
Is Maravai LifeSciences Holdings' Market Cap too high?
Maravai LifeSciences Holdings' current Market Cap is MXN16,513 Mil. Based on the distribution chart, Maravai LifeSciences Holdings ranks #291 out of 1428 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Maravai LifeSciences Holdings has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Market Cap compare to LBRX and SLDB?
According to the Biotechnology industry distribution chart, Maravai LifeSciences Holdings ranks #291 out of 1428 companies for Market Cap. This places Maravai LifeSciences Holdings in the top 20% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.44, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Maravai LifeSciences Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 119.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maravai LifeSciences Holdings's current Market Cap is MXN16,513 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Market Cap of MXN16,513 Mil. The stock's GF Value™ is MXN52.37, compared to a current price of MXN85.00 — trading 62.3% above its estimated fair value. The current Market Cap is MXN16,513 Mil. Maravai LifeSciences Holdings' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Market Cap is MXN16,513 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of MXN85.00 is trading 62.3% above its estimated GF Value™ of MXN52.37.

Key valuation signals for MEX:MRVI:

  • Market Cap: MXN16,513 Mil
  • GF Value™: MXN52.37 vs. price of MXN85.00 (62.3% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USAMAR:Germany
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score

Get the complete analysis for MEX:MRVI

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.00
Price
MXN52.37
GF Value